DeuterOncology (Public limited company)
DeuterOncology is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0754.971.388. It was founded on 28-09-2020. Its registered office is in Liège. Its main activity is: Manufacture of basic pharmaceutical products and pharmaceutical preparations. Its annual accounts for 2025 report equity of € -2 635 237 and a loss of € 3 600 784. These accounts report 0 full-time equivalents. Addrly gives it a financial health grade of D, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 4 financial years.
Information last updated on 17-10-2026.
Company information
Key figures of DeuterOncology
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
Profit / lossiWhat the period earned after taxes. A negative amount is a loss. | € -3 600 784-70 % | € -2 114 850-4 % | € -2 029 591+15 % | € -2 387 844 |
EquityiWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company. | € -2 635 237 | € 965 547-43 % | € 1 707 402-48 % | € 3 309 968 |
Total assetsiEverything the company owns. Equal to total equity and liabilities, which says how it is financed. | € 688 028-46 % | € 1 271 170-36 % | € 1 976 413-45 % | € 3 603 673 |
Gross marginiSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else. | € -3 279 454-65 % | € -1 987 149-7 % | € -1 864 132+19 % | € -2 294 417 |
Employees (FTE)iAverage number of workers over the period, in full-time equivalents. | 0 | 0 | 0 | - |
Financial estimate
- 2 Shareholders
- 1 Subsidiaries
- 3 Board links
Similar companies
Other companies in the same activity in Liège.
| Company | Town |
|---|---|
| LABORATOIRES LOHMANN & RAUSCHER | 4000 Liège |
| Jenatzy Engineering | 4000 Liège |
| CREATIQUE | 4000 Liège |
| Smash 51 | 4000 Liège |
| Mithra Pharmaceuticals | 4000 Liège |
| ZENOBE | 4000 Liège |
| THERMIVENT II | 4000 Liège |
| SOFINTRA | 4000 Liège |
Frequently asked questions
Is DeuterOncology still active? Yes. The Crossroads Bank for Enterprises lists DeuterOncology as active.
What is the VAT number of DeuterOncology? The VAT number of DeuterOncology is BE 0754.971.388.
When was DeuterOncology founded? DeuterOncology was founded on 28-09-2020.
What is the address of DeuterOncology? The current registered office of DeuterOncology is Clos Chanmurly 13, 4000 Liège.
When did DeuterOncology last file annual accounts? The latest annual accounts of DeuterOncology were filed on 23-06-2026.
Does DeuterOncology file its annual accounts on time? Yes. DeuterOncology filed its annual accounts within the legal deadline for each of its last 4 financial years.
How many employees does DeuterOncology have? DeuterOncology employs 0 full-time equivalents according to its most recent annual accounts.
Is DeuterOncology financially healthy? Addrly gives DeuterOncology a financial health grade of D, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.
Is DeuterOncology profitable? The annual accounts of DeuterOncology for 2025 show a loss of € 3 600 784.
What is the equity of DeuterOncology? The equity of DeuterOncology was € -2 635 237 at the close of the 2025 financial year.
Who are the directors of DeuterOncology? The annual accounts of DeuterOncology record 11 mandates. The names, roles and dates are visible with a free account.
Can DeuterOncology receive Peppol e-invoices? Yes. DeuterOncology is registered on the Peppol network and can receive structured electronic invoices.
What does DeuterOncology do? The main activity of DeuterOncology is: Manufacture of basic pharmaceutical products and pharmaceutical preparations.